BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 18365884)

  • 21. Quillaja brasiliensis saponins induce robust humoral and cellular responses in a bovine viral diarrhea virus vaccine in mice.
    Cibulski SP; Silveira F; Mourglia-Ettlin G; Teixeira TF; dos Santos HF; Yendo AC; de Costa F; Fett-Neto AG; Gosmann G; Roehe PM
    Comp Immunol Microbiol Infect Dis; 2016 Apr; 45():1-8. PubMed ID: 27012913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spray dried cubosomes with ovalbumin and Quil-A as a nanoparticulate dry powder vaccine formulation.
    von Halling Laier C; Gibson B; van de Weert M; Boyd BJ; Rades T; Boisen A; Hook S; Nielsen LH
    Int J Pharm; 2018 Oct; 550(1-2):35-44. PubMed ID: 30134183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Time course study of the antigen-specific immune response to a PLGA microparticle vaccine formulation.
    Wang Q; Tan MT; Keegan BP; Barry MA; Heffernan MJ
    Biomaterials; 2014 Sep; 35(29):8385-93. PubMed ID: 24986256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diaminosulfide based polymer microparticles as cancer vaccine delivery systems.
    Geary SM; Hu Q; Joshi VB; Bowden NB; Salem AK
    J Control Release; 2015 Dec; 220(Pt B):682-90. PubMed ID: 26359124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancement of adaptive immunity by the human vaccine adjuvant AS01 depends on activated dendritic cells.
    Didierlaurent AM; Collignon C; Bourguignon P; Wouters S; Fierens K; Fochesato M; Dendouga N; Langlet C; Malissen B; Lambrecht BN; Garçon N; Van Mechelen M; Morel S
    J Immunol; 2014 Aug; 193(4):1920-30. PubMed ID: 25024381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angelica sinensis polysaccharide encapsulated into PLGA nanoparticles as a vaccine delivery and adjuvant system for ovalbumin to promote immune responses.
    Gu P; Liu Z; Sun Y; Ou N; Hu Y; Liu J; Wu Y; Wang D
    Int J Pharm; 2019 Jan; 554():72-80. PubMed ID: 30399435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel ISCOMs from Quillaja brasiliensis saponins induce mucosal and systemic antibody production, T-cell responses and improved antigen uptake.
    Cibulski SP; Mourglia-Ettlin G; Teixeira TF; Quirici L; Roehe PM; Ferreira F; Silveira F
    Vaccine; 2016 Feb; 34(9):1162-71. PubMed ID: 26826546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paracrine release of IL-12 stimulates IFN-gamma production and dramatically enhances the antigen-specific T cell response after vaccination with a novel peptide-based cancer vaccine.
    Salem ML; Kadima AN; Zhou Y; Nguyen CL; Rubinstein MP; Demcheva M; Vournakis JN; Cole DJ; Gillanders WE
    J Immunol; 2004 May; 172(9):5159-67. PubMed ID: 15100252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isolation and evaluation of immunological adjuvant activities of saponins from the roots of Pulsatilla chinensis with less adverse reactions.
    Sun Y; Liu J; Yu H; Gong C
    Int Immunopharmacol; 2010 May; 10(5):584-90. PubMed ID: 20159051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The administration route is decisive for the ability of the vaccine adjuvant CAF09 to induce antigen-specific CD8(+) T-cell responses: The immunological consequences of the biodistribution profile.
    Schmidt ST; Khadke S; Korsholm KS; Perrie Y; Rades T; Andersen P; Foged C; Christensen D
    J Control Release; 2016 Oct; 239():107-17. PubMed ID: 27574990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation and Characterization of an Oral Vaccine Formulation Using Electrosprayed Chitosan Microparticles.
    Moreno JAS; Panou DA; Stephansen K; Chronakis IS; Boisen A; Mendes AC; Nielsen LH
    AAPS PharmSciTech; 2018 Nov; 19(8):3770-3777. PubMed ID: 30280354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Silica vesicles as nanocarriers and adjuvants for generating both antibody and T-cell mediated immune resposes to Bovine Viral Diarrhoea Virus E2 protein.
    Mody KT; Mahony D; Zhang J; Cavallaro AS; Zhang B; Popat A; Mahony TJ; Yu C; Mitter N
    Biomaterials; 2014 Dec; 35(37):9972-9983. PubMed ID: 25239045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines.
    Patel GB; Zhou H; Ponce A; Chen W
    Vaccine; 2007 Dec; 25(51):8622-36. PubMed ID: 17959279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanopatch targeted delivery of both antigen and adjuvant to skin synergistically drives enhanced antibody responses.
    Fernando GJ; Chen X; Primiero CA; Yukiko SR; Fairmaid EJ; Corbett HJ; Frazer IH; Brown LE; Kendall MA
    J Control Release; 2012 Apr; 159(2):215-21. PubMed ID: 22306334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjuvant effect of Panax notoginseng saponins on the immune responses to ovalbumin in mice.
    Sun HX; Ye YP; Pan HJ; Pan YJ
    Vaccine; 2004 Sep; 22(29-30):3882-9. PubMed ID: 15364435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of polyanhydride chemistry in particle-based cancer vaccines on the magnitude of the anti-tumor immune response.
    Wafa EI; Geary SM; Goodman JT; Narasimhan B; Salem AK
    Acta Biomater; 2017 Mar; 50():417-427. PubMed ID: 28063991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liposomes containing monophosphoryl lipid A and QS-21 serve as an effective adjuvant for soluble circumsporozoite protein malaria vaccine FMP013.
    Genito CJ; Beck Z; Phares TW; Kalle F; Limbach KJ; Stefaniak ME; Patterson NB; Bergmann-Leitner ES; Waters NC; Matyas GR; Alving CR; Dutta S
    Vaccine; 2017 Jul; 35(31):3865-3874. PubMed ID: 28596090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice.
    Tada R; Muto S; Iwata T; Hidaka A; Kiyono H; Kunisawa J; Aramaki Y
    BMC Res Notes; 2017 Jan; 10(1):68. PubMed ID: 28126014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. pH Sensitive phosphorylated chitosan hydrogel as vaccine delivery system for intramuscular immunization.
    Wei J; Xue W; Yu X; Qiu X; Liu Z
    J Biomater Appl; 2017 May; 31(10):1358-1369. PubMed ID: 28387574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First in vivo evaluation of particulate nasal dry powder vaccine formulations containing ovalbumin in mice.
    Scherließ R; Mönckedieck M; Young K; Trows S; Buske S; Hook S
    Int J Pharm; 2015 Feb; 479(2):408-15. PubMed ID: 25595389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.